Yahoo
HKSE - Delayed Quote HKD

Gaush Meditech Ltd (2407.HK)

4.445 +0.045 (+1.02%)
At close: 3:53:36 PM GMT+8
Chart Range Bar
Loading chart for 2407.HK
  • Previous Close 4.400
  • Open 4.560
  • Bid 4.360 x --
  • Ask 4.445 x --
  • Day's Range 4.360 - 4.560
  • 52 Week Range 3.800 - 9.440
  • Volume 16,400
  • Avg. Volume 15,600
  • Market Cap (intraday) 657.362M
  • Beta (5Y Monthly) -0.00
  • PE Ratio (TTM) 7.53
  • EPS (TTM) 0.590
  • Earnings Date (est.) --
  • Forward Dividend & Yield 0.30 (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

Gaush Meditech Ltd. engages in research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company's product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, refractive surgery, glaucoma, ocular surface diseases, optometry, and pediatric ophthalmology. The company was founded in 1998 and is headquartered in Beijing, China.

www.gaush.com

890

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2407.HK
44.85%
HANG SENG INDEX (^HSI)
4.48%

1-Year Return

2407.HK
50.50%
HANG SENG INDEX (^HSI)
7.57%

3-Year Return

2407.HK
87.02%
HANG SENG INDEX (^HSI)
36.26%

5-Year Return

2407.HK
91.32%
HANG SENG INDEX (^HSI)
1.56%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.71%

  • Return on Assets (ttm)

    2.15%

  • Return on Equity (ttm)

    4.22%

  • Revenue (ttm)

    1.32B

  • Net Income Avi to Common (ttm)

    75.49M

  • Diluted EPS (ttm)

    0.590

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    353.32M

  • Total Debt/Equity (mrq)

    24.23%

  • Levered Free Cash Flow (ttm)

    76.97M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: